glycine and glp 1 GLP-1_GIP_Glycine_Injection_550x.png?v=1776143217 Full-length human GLP-1 receptor structure
Description
This is the unlikely journey from desert predator to medical marvel.
The Semaglutide Shift: Indias Next Big Move in Healthcare The Indian pharmaceutical landscape is hitting a major turning point this month
PBMs play a critical role in managing prescription drug costs for employers yet many struggle with how to compare PBM proposals.
New analysis suggests that negotiated pricing still falls short of achieving cost neutrality if GLP-1 drug coverage expands to include weight management.
Fierce Pharma article, 21 January 2023: [7] [8]
A small human proof-of-concept trial reported that semaglutide reduced vastus lateralis cross-sectional area but did not reduce knee-extension strength or grip strength over 12 weeks
